Análisis de costo-efectividad del condroitín más glucosamina comparado con acetaminofén, AINEs y celecoxib para el tratamiento sintomático de adultos con osteoartrosis de rodilla y mano en Colombia

Dieleman, Sabrina; Moreno, Mabel; Díaz Ortega, Miguel Hernando; Vanegas Escamilla, Egdda Patricia.
Bogotá; IETS; mayo 2016. 46 p. tab, ilus, graf.
Monografia em Espanhol | LILACS, BRISA | ID: biblio-846626

Documentos relacionados

  1. A systematic review and trial sequential analysis of intravenous vs. oral peri-operative paracetamol.
  2. Fund Black scientists.
  3. Development and Impact of an Institutional Enhanced Recovery Program on Opioid Use, Length of Stay, and Hospital Costs Within an Academic Medical Center: A Cohort Analysis of 7774 Patients.
  4. Attitude changes in prescribing intravenous iron supplementation in different settings at a hospital consortium in Italy.
  5. Principal-agent theory-based cost and reimbursement structures of isavuconazole treatment in German hospitals.
  6. Environmental considerations with peri-operative simple analgesics.
  7. From scientific discovery to cures: bright stars within a galaxy.
  8. Cost-effectiveness of generic celecoxib in knee osteoarthritis for average-risk patients: a model-based evaluation.
  9. The pros and cons of animal health harmonisation.
  10. Global access to affordable direct oral anticoagulants.